The tests identify specific foods that may trigger inflammation in patients with Crohn's disease and ulcerative colitis.
COVID-19 pandemic-related decreases in fecal immunochemical test (FIT) administration, FIT positivity, colonoscopy, and colonoscopy-related detection of neoplasia among patients a ...
Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union ...
In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ...
Governors’ legacies often are complicated, and former Gov. Jim Guy Tucker’s is more complicated than most. This can be said: ...
A popular US fast food chain is handing Robert F. Kennedy Jr. one of his first big wins as US Secretary of Health and Human ...
Biomerica (BMRA) announces that its food intolerance products for Crohn’s Disease and Ulcerative Colitis have achieved CE-marking under the ...
Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...
Johnson & Johnson (J&J) has shared positive results from a late-stage study evaluating a subcutaneous (SC) version of Tremfya ...
Drinking more milk was linked to an increase in bacteria that may support gut health, while consuming more cheese seemed to ...
"When I was about 28, I was like; 'I've had enough'. I demanded that I see a gynaecologist or I would go to the complaints ...
Immunic presents key data on vidofludimus calcium at ACTRIMS Forum 2025, highlighting its potential in multiple sclerosis. Phase 2 CALLIPER trial results expected in April ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results